RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Graves ophthalmopathy
Accession: DOID:0081120
browse the term
Definition: An autoimmune disease of eyes, ear, nose and throat that is characterized by upper eyelid retraction, lid lag, swelling, redness, conjunctivitis, and bulging eyes. (DO)
Synonyms: exact_synonym: Congestive Ophthalmopathies; Congestive Ophthalmopathy; Dysthyroid Ophthalmopathies; Dysthyroid Ophthalmopathy; Edematous Ophthalmopathies; Edematous Ophthalmopathy; Infiltrative Ophthalmopathies; Infiltrative Ophthalmopathy; Myopathic Ophthalmopathies; Myopathic Ophthalmopathy; Thyroid Associated Ophthalmopathies; Thyroid Associated Ophthalmopathy; Thyroid Eye Disease
narrow_synonym: Graves' Orbitopathy; Thyroid-Associated Orbitopathy
primary_id: MESH:D049970
alt_id: DOID:9000008
G
CAT
catalase
treatment
ISO
protein:decreased activity:blood: protein:increased activity:plasma:
RGD
PMID:15158621 PMID:20394549
RGD:9071200 RGD:9086875
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL2
C-C motif chemokine ligand 2
ISO
mRNA:increased expression:orbital fat (human)
RGD
PMID:18284633
RGD:8549459
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association severity
ISO
protein:increased expression:serum: associated with Graves Disease; DNA:SNP:promoter:-318C>T (human)
RGD
PMID:16893393 PMID:19734241 PMID:22663548
RGD:7421511 RGD:7421521 RGD:7421523
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
ICAM1
intercellular adhesion molecule 1
ISO
DNA:polymorphism: :c.1405A>G (human)
RGD
PMID:14557478
RGD:8158124
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IFNG
interferon gamma
ISO
RGD
PMID:8444271
RGD:7794734
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IGF1
insulin like growth factor 1
ISO
mRNA,protein:increased expression,increased excretion:orbital tissue:
RGD
PMID:22159761
RGD:8548854
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
IL10
interleukin 10
ISO
DNA:SNP:promoter:-819C>T (human) protein:increased expression:serum
RGD
PMID:11753760 PMID:21067483
RGD:7364859 RGD:7365083
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:12689659
RGD:8655878
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1A
interleukin 1 alpha
ISO
RGD
PMID:8444271
RGD:7794734
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
IL1RN
interleukin 1 receptor antagonist
severity susceptibility
ISO
protein:increased expression:serum (human) DNA:snp:exon:11100 C>T (rs315952) (human)
RGD
PMID:12186498 PMID:19702713
RGD:7387296 RGD:8549808
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
IL2
interleukin 2
ISO
RGD
PMID:2786308
RGD:8662939
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL23R
interleukin 23 receptor
no_association susceptibility
ISO
DNA:SNPs: :rs10889677,rs2201841(human) DNA:SNPs: :rs2201841,rs10889677(human)
RGD
PMID:18073300 PMID:22663548
RGD:7421521 RGD:8549554
NCBI chr 1:66,408,839...66,502,535
Ensembl chr 1:68,293,514...68,386,815
G
IL3
interleukin 3
ISO
DNA: SNP: : rs40401
RGD
PMID:20332709
RGD:5686901
NCBI chr 5:127,483,843...127,486,388
Ensembl chr 5:133,647,667...133,650,213
G
KIF1A
kinesin family member 1A
ISO
RGD
PMID:26451909
RGD:12911230
NCBI chr2B:127,969,494...128,078,282
Ensembl chr2B:246,778,679...246,860,326
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
mRNA:increased expression:orbital fat (human)
RGD
PMID:14588098
RGD:8552818
NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17614770
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
ISO
DNA:SNPs: :rs1468682, rs4729535 and rs17467232 (human)
RGD
PMID:17608818
RGD:7829763
NCBI chr 1:88,685,736...88,743,164
Ensembl chr 1:123,734,511...123,790,830
G
SCD
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17614770
NCBI chr10:96,948,212...96,965,633
Ensembl chr10:100,429,615...100,442,776
G
SERPINE1
serpin family E member 1
severity
ISO
associated with Graves Disease;protein:increased expression:tears (human)
RGD
PMID:22385289
RGD:8547756
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
TNF
tumor necrosis factor
susceptibility
ISO
DNA:SNP:promoter:-238G>A (rs361525) (human) DNA:SNP:promoter:-863C>A (human)
RGD
PMID:8444271 PMID:15219383 PMID:16191343
RGD:12904066 RGD:7365073 RGD:7794734
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TSHR
thyroid stimulating hormone receptor
severity
ISO
DNA:SNP:intron:rs179247 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20237164 PMID:22673349 PMID:31705858
RGD:8548662 RGD:8548673
NCBI chr14:61,517,767...61,708,241
Ensembl chr14:80,718,433...80,905,890
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all